NATCO Pharma Limited Stock Forecast
Red day on Monday for NATCO Pharma Limited
(Updated on Jun 24, 2024)
The NATCO Pharma Limited stock price fell by -0.375% on the last day (Monday, 24th Jun 2024) from ₹1,200.65 to ₹1,196.15. During the last trading day the stock fluctuated 2.43% from a day low at ₹1,190.00 to a day high of ₹1,218.90. The price has risen in 6 of the last 10 days and is up by 10.5% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -454 thousand shares and in total, 961 thousand shares were bought and sold for approximately ₹1.15 billion.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at ₹1,224.75 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 16.41% during the next 3 months and, with a 90% probability hold a price between ₹1,172.36 and ₹1,425.67 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NATCOPHARM.NS Signals & Forecast
The NATCO Pharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹1,190.96 and ₹1,054.92. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 14, 2024, and so far it has fallen -1.19%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for NATCO Pharma Limited stock
NATCO Pharma Limited finds support from accumulated volume at ₹1,172.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ₹28.90 between high and low, or 2.43%. For the last week, the stock has had daily average volatility of 3.65%.
The NATCO Pharma Limited stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: ₹1,153.00 (-3.61%) (This stock has high daily movements and this gives high risk. The RSI14 is 78 and this increases the risk substantially. There is a sell signal from a pivot top found 13 days ago.)
Trading Expectations (NATCOPHARM.NS) For The Upcoming Trading Day Of Tuesday 25th
For the upcoming trading day on Tuesday, 25th we expect NATCO Pharma Limited to open at ₹1,201.68, and during the day (based on 14 day Average True Range), to move between ₹1,154.87 and ₹1,237.43, which gives a possible trading interval of +/-₹41.28 (+/-3.45%) up or down from last closing price. If NATCO Pharma Limited takes out the full calculated possible swing range there will be an estimated 6.90% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at ₹1,200.65 (0.38%) than the support at ₹1,172.35 (1.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is NATCO Pharma Limited stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NATCO Pharma Limited stock to perform well in the short-term.
Current score: 1.309 Buy Candidate Unchanged
Predicted Opening Price for NATCO Pharma Limited of Tuesday, June 25, 2024
| Fair opening price June 25, 2024 | Current price |
|---|---|
| ₹1,201.68 ( 0.463%) | ₹1,196.15 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NATCOPHARM.NS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1,230.58 | 2.88% |
| R2 | 1,219.54 | 1.96% |
| R1 | 1,212.72 | 1.39% |
| Price | 1,196.15 | |
| S1 | 1,190.64 | -0.460% |
| S2 | 1,183.82 | -1.03% |
| S3 | 1,172.78 | -1.95% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1,210.60 | 1.21% |
| R2 | 1,206.15 | 0.84% |
| R1 | 1,200.65 | 0.376% |
| Price | 1,196.15 | |
| S1 | 1,172.35 | -1.99% |
| S2 | 1,032.30 | -13.70% |
| S3 | 1,015.20 | -15.13% |
NATCOPHARM Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 26, 2024 | Feb 26, 2024 | Mar 04, 2024 | ₹1.25 | 0.126% |
| 2 | Nov 24, 2023 | Nov 24, 2023 | Dec 14, 2023 | ₹1.25 | 0.163% |
| 3 | Aug 22, 2023 | Aug 22, 2023 | Sep 08, 2023 | ₹7.00 | 0.794% |
| 4 | Feb 21, 2023 | Feb 21, 2023 | Feb 21, 2023 | ₹1.25 | 0.228% |
| 5 | Nov 21, 2022 | Nov 21, 2022 | Nov 21, 2022 | ₹0.750 | 0.132% |
FAQ
Click here for our free guide on how to buy NATCO Pharma Limited Stock.
